Picard Medical, Inc. (PMI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed on May 15, 2026, by Picard Medical, Inc., a Delaware corporation listed on the NYSE American under the symbol "PMI." The filing primarily addresses regulatory compliance issues regarding continued listing standards and references financial results for the first quarter ended March 31, 2026, which were announced in a press release dated May 21, 2026.
Key Financial Metrics
The filing provides limited specific financial data, referencing a press release for full details. Key disclosed metrics include:
- Stockholders' Equity: A deficit of approximately $1.4 million as of March 31, 2026.
- Profitability: The Company has incurred losses from continuing operations and/or net losses in each of its three most recent fiscal years ended December 31, 2025.
- Revenue, Cash Flow, and Debt: The filing text does not provide clear values for revenue, operating cash flow, or specific debt obligations.
Material Changes and Listing Status
The Company received two notices from the NYSE American regarding non-compliance with continued listing standards:
- May 8, 2026 Notice: Non-compliance with Section 1003(a)(ii) of the NYSE American Company Guide.
- May 15, 2026 Notice: Non-compliance with Section 1003(a)(i), which requires stockholders' equity of at least $2.0 million for companies reporting losses in two of their three most recent fiscal years.
- Trading Designation: The Company's stock continues to trade but carries a ".BC" designation indicating compliance issues.
Outlook, Risks, and Contingencies
The Company is preparing a compliance plan (the "Plan") to be submitted to the NYSE American by June 7, 2026. The plan must outline actions to regain compliance by November 8, 2027.
- Delisting Risk: If the Plan is not submitted, not accepted, or if the Company fails to meet compliance standards by November 8, 2027, or fails to make consistent progress, the Company will be subject to delisting procedures.
- Operational Impact: The notices have no immediate effect on the Company's ongoing business operations or SEC reporting requirements.
Investor Verification Checklist
- Verify the full text of the May 21, 2026 press release (Exhibit 99.1) for detailed Q1 2026 revenue and cash flow figures.
- Monitor the submission and acceptance of the compliance Plan by the June 7, 2026 deadline.
- Review the Company's capitalization strategy to address the $1.4 million stockholders' deficit.
- Track the ".BC" trading designation status on the NYSE American.